Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 42 publications
(3 reference statements)
0
3
0
Order By: Relevance
“… 24 It has been shown that ischemia and reperfusion initiates this apoptotic cascade in cells. 25 When cell death is inhibited, organ function is significantly improved during ischemia and reperfusion. 6 , 25 Some studies has been reported that DEX preconditioning attenuates cell death and improves organ function during ischemia-reperfusion injury.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“… 24 It has been shown that ischemia and reperfusion initiates this apoptotic cascade in cells. 25 When cell death is inhibited, organ function is significantly improved during ischemia and reperfusion. 6 , 25 Some studies has been reported that DEX preconditioning attenuates cell death and improves organ function during ischemia-reperfusion injury.…”
Section: Discussionmentioning
confidence: 99%
“… 25 When cell death is inhibited, organ function is significantly improved during ischemia and reperfusion. 6 , 25 Some studies has been reported that DEX preconditioning attenuates cell death and improves organ function during ischemia-reperfusion injury. 6 In this experiment, consistent with attenuated apoptosis, we also found that DEX preconditioning reduced protein and cell content in BAL and decreased the pathology score in lung tissue, indicating that DEX pretreatment significantly improves lung injury caused by ischemia and reperfusion.…”
Section: Discussionmentioning
confidence: 99%
“…4,5 Remote ischemic preconditioning (RIPC) is a powerful protective treatment against subsequent and more severe ischemic organ damage caused by transient events of ischemia on a distant tissue or organ. [6][7][8][9][10][11] Intraperitoneal (IP) injection of lipopolysaccharide (LPS) is a common experimental model in mice for LPS-induced ALI from a non-pulmonary origin. This model features major pathological components of ALI, such as profound neutrophilic infiltration, vascular leakage/lung edema, and alveolar hemorrhage, all of which are observed in patients with ALI.…”
Section: Introductionmentioning
confidence: 99%